What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Asthma
- Disease
Sejal Saglani mainly investigates Asthma, Immunology, Internal medicine, Airway and Biopsy.
Sejal Saglani has included themes like Inflammation, Bronchoalveolar lavage and Allergy in his Asthma study.
Sejal Saglani studied Immunology and Vitamin D and neurology that intersect with Case-control study and Prospective cohort study.
As part of one scientific family, he deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Wheeze.
His Biopsy research is multidisciplinary, incorporating elements of Lung and Bronchoscopy.
The concepts of his Bronchodilator study are interwoven with issues in Respiratory disease and Surgery.
His most cited work include:
- Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. (405 citations)
- Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. (321 citations)
- Lung microbiota promotes tolerance to allergens in neonates via PD-L1 (317 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Asthma, Immunology, Pediatrics, Airway and Internal medicine.
His studies deal with areas such as Disease and Intensive care medicine as well as Asthma.
As a part of the same scientific study, Sejal Saglani usually deals with the Immunology, concentrating on Vitamin D and neurology and frequently concerns with Interleukin 10.
His Airway study integrates concerns from other disciplines, such as Biopsy, Cystic fibrosis, Respiratory system and Bronchoscopy.
Sejal Saglani has included themes like Gastroenterology and Allergy in his Internal medicine study.
Sejal Saglani interconnects Bronchoalveolar lavage and Eosinophilic in the investigation of issues within Eosinophilia.
He most often published in these fields:
- Asthma (65.60%)
- Immunology (38.07%)
- Pediatrics (23.39%)
What were the highlights of his more recent work (between 2017-2021)?
- Asthma (65.60%)
- Pediatrics (23.39%)
- Wheeze (18.35%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Asthma, Pediatrics, Wheeze, Immunology and Disease.
His work carried out in the field of Asthma brings together such families of science as Incidence, Eosinophilia, Intensive care medicine, Airway and Cohort.
His Eosinophilia research integrates issues from ALLERGEN EXPOSURE, Bronchoscopy, Eosinophilic and Bronchoalveolar lavage, Lung.
His study in Pediatrics is interdisciplinary in nature, drawing from both Rhinovirus, Endotype and Optimal management.
His Wheeze study is related to the wider topic of Internal medicine.
His Disease research incorporates themes from Young adult, Childhood asthma and Interleukin 5.
Between 2017 and 2021, his most popular works were:
- Childhood Asthma: Advances Using Machine Learning and Mechanistic Studies. (25 citations)
- Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids (22 citations)
- The relationship between inflammation and remodeling in childhood asthma: A systematic review (22 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Asthma
- Disease
His primary areas of study are Asthma, Intensive care medicine, Airway, Immunology and Eosinophilia.
His Asthma study incorporates themes from Disease, Pediatrics and Bronchoscopy.
The study incorporates disciplines such as Mepolizumab, Severe asthma, Precision medicine and Clinical trial in addition to Intensive care medicine.
The Airway study combines topics in areas such as Wheeze and Etiology.
His research in Eosinophilia intersects with topics in Lung and Eosinophilic.
His work in Eosinophilic covers topics such as Bronchodilator which are related to areas like Spirometry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
